Skip to main content
OpenTrials

Clinical trial condition

Non Small Cell Lung Cancer

Explore clinical trials studying Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

671 public trials 177 recruiting studies
Refine in advanced search Browse all conditions

Non Small Cell Lung Cancer trial results

Completed

Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients

NCT00457119

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Georgetown University/Lombardi Cancer Center StudyCoordinator:CRAD001C2114 Washington D.C., District of Columbia, United States
  • LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Feist-Weiller Cancer Center New Orleans, Louisiana, United States
  • U of TX Southwestern Medical Center - SimmonsCompCancerCtr Clinical Research Office Dallas, Texas, United States
  • MD Anderson Cancer Center/University of Texas Thoractic Head/Neck Med. Onc. Houston, Texas, United States
View Trial Details
Completed

Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations

NCT00891579

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Lung Cancer Research Institute & Cancer Center of Guangdong General Hospital Guangzhou, Guangdong, China
  • 307 hospital of People's Liberation Army Beijing, China
  • Peking Union Hospital Beijing, China
  • Jilin Tumor Hospital Changchun, China
View Trial Details
Completed

Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer

NCT00095199

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montgomery, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucson, Arizona, United States
View all 67 locations
View Trial Details

Related conditions